AOD-9604 — The Precision Fat Loss Peptide That Targets Stubborn Adipose Tissue
|

AOD-9604 — The Precision Fat Loss Peptide That Targets Stubborn Adipose Tissue

ByGareth

AOD-9604 — The Precision Fat Loss Peptide That Targets Stubborn Adipose Tissue AOD-9604 Sometimes the most interesting compounds are not the ones that make the biggest headlines. While semaglutide and tirzepatide have dominated the weight loss conversation with their dramatic clinical trial numbers, AOD-9604 has quietly built a committed and loyal following in the research…

Retatrutide — The Triple Agonist That Is Rewriting the Rules of Weight Loss
|

Retatrutide — The Triple Agonist That Is Rewriting the Rules of Weight Loss

ByGareth

Retatrutide — The Triple Agonist That Is Rewriting the Rules of Weight Loss 28.7% average body weight reduction. In a Phase 3 clinical trial. Over 68 weeks. To put that number in context — most bariatric surgery procedures produce average weight loss of between 25% and 30%. The most effective pharmaceutical compound previously available —…

End of content

End of content